TREACE MEDICAL CONCEPTS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Treace Medical Concepts, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Treace Medical Concepts, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $35.2M, a 54% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $35.2M +$12.3M +54% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $22.9M +$10.9M +91.5% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $11.9M +$6.44M +117% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $3.5M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $5.5M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $4.9M Mar 31, 2021 10-Q 2021-05-25
Q4 2020 $5.5M Dec 31, 2020 10-K 2022-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.